Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03440567
Brief Title: Avelumab, Utomilumab, Rituximab, Ibrutinib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma

First Submitted : February 2, 2018
First Submitted that Met QC Criteria : February 19, 2018
First Posted : February 21, 2018 (Estimate)

Last Update Submitted that Met QC Criteria : December 10, 2018
Last Update Posted : December 12, 2018